These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 30924022)
1. The Osteocyte as a Novel Key Player in Understanding Periodontitis Through its Expression of RANKL and Sclerostin: a Review. de Vries TJ; Huesa C Curr Osteoporos Rep; 2019 Jun; 17(3):116-121. PubMed ID: 30924022 [TBL] [Abstract][Full Text] [Related]
2. Receptor activator of nuclear factor-κB ligand and sclerostin expression in osteocytes of alveolar bone in rats with ligature-induced periodontitis. Kim JH; Lee DE; Cha JH; Bak EJ; Yoo YJ J Periodontol; 2014 Nov; 85(11):e370-8. PubMed ID: 25070541 [TBL] [Abstract][Full Text] [Related]
3. The roles of osteocytes in alveolar bone destruction in periodontitis. Huang X; Xie M; Xie Y; Mei F; Lu X; Li X; Chen L J Transl Med; 2020 Dec; 18(1):479. PubMed ID: 33308247 [TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor-α antagonist diminishes osteocytic RANKL and sclerostin expression in diabetes rats with periodontitis. Kim JH; Kim AR; Choi YH; Jang S; Woo GH; Cha JH; Bak EJ; Yoo YJ PLoS One; 2017; 12(12):e0189702. PubMed ID: 29240821 [TBL] [Abstract][Full Text] [Related]
6. Osteocyte RANKL Drives Bone Resorption in Mouse Ligature-Induced Periodontitis. Kittaka M; Yoshimoto T; Levitan ME; Urata R; Choi RB; Teno Y; Xie Y; Kitase Y; Prideaux M; Dallas SL; Robling AG; Ueki Y J Bone Miner Res; 2023 Oct; 38(10):1521-1540. PubMed ID: 37551879 [TBL] [Abstract][Full Text] [Related]
7. Osteocytes play an important role in experimental periodontitis in healthy and diabetic mice through expression of RANKL. Graves DT; Alshabab A; Albiero ML; Mattos M; Corrêa JD; Chen S; Yang Y J Clin Periodontol; 2018 Mar; 45(3):285-292. PubMed ID: 29220094 [TBL] [Abstract][Full Text] [Related]
8. Sclerostin stimulates osteocyte support of osteoclast activity by a RANKL-dependent pathway. Wijenayaka AR; Kogawa M; Lim HP; Bonewald LF; Findlay DM; Atkins GJ PLoS One; 2011; 6(10):e25900. PubMed ID: 21991382 [TBL] [Abstract][Full Text] [Related]
10. Sclerostin and its role as a bone modifying agent in periodontal disease. Ashifa N; Viswanathan K; Sundaram R; Srinivasan S J Oral Biosci; 2021 Jun; 63(2):104-110. PubMed ID: 33878470 [TBL] [Abstract][Full Text] [Related]
11. Osteocyte TSC1 promotes sclerostin secretion to restrain osteogenesis in mice. Liu W; Wang Z; Yang J; Wang Y; Li K; Huang B; Yan B; Wang T; Li M; Zou Z; Yang J; Xiao G; Cui ZK; Liu A; Bai X Open Biol; 2019 May; 9(5):180262. PubMed ID: 31088250 [TBL] [Abstract][Full Text] [Related]
12. Osteocyte-Mediated Translation of Mechanical Stimuli to Cellular Signaling and Its Role in Bone and Non-bone-Related Clinical Complications. Yan Y; Wang L; Ge L; Pathak JL Curr Osteoporos Rep; 2020 Feb; 18(1):67-80. PubMed ID: 31953640 [TBL] [Abstract][Full Text] [Related]
13. Osteocytes directly regulate osteolysis via MYD88 signaling in bacterial bone infection. Yoshimoto T; Kittaka M; Doan AAP; Urata R; Prideaux M; Rojas RE; Harding CV; Henry Boom W; Bonewald LF; Greenfield EM; Ueki Y Nat Commun; 2022 Nov; 13(1):6648. PubMed ID: 36333322 [TBL] [Abstract][Full Text] [Related]
14. Osteocyte control of bone remodeling: is sclerostin a key molecular coordinator of the balanced bone resorption-formation cycles? Sapir-Koren R; Livshits G Osteoporos Int; 2014 Dec; 25(12):2685-700. PubMed ID: 25030653 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of osteocyte apoptosis prevents the increase in osteocytic receptor activator of nuclear factor κB ligand (RANKL) but does not stop bone resorption or the loss of bone induced by unloading. Plotkin LI; Gortazar AR; Davis HM; Condon KW; Gabilondo H; Maycas M; Allen MR; Bellido T J Biol Chem; 2015 Jul; 290(31):18934-42. PubMed ID: 26085098 [TBL] [Abstract][Full Text] [Related]
17. FOXO1 Mediates Advanced Glycation End Products Induced Mouse Osteocyte-Like MLO-Y4 Cell Apoptosis and Dysfunctions. Zhang C; Wei W; Chi M; Wan Y; Li X; Qi M; Zhou Y J Diabetes Res; 2019; 2019():6757428. PubMed ID: 31886284 [TBL] [Abstract][Full Text] [Related]
18. Bidirectional Notch Signaling and Osteocyte-Derived Factors in the Bone Marrow Microenvironment Promote Tumor Cell Proliferation and Bone Destruction in Multiple Myeloma. Delgado-Calle J; Anderson J; Cregor MD; Hiasa M; Chirgwin JM; Carlesso N; Yoneda T; Mohammad KS; Plotkin LI; Roodman GD; Bellido T Cancer Res; 2016 Mar; 76(5):1089-100. PubMed ID: 26833121 [TBL] [Abstract][Full Text] [Related]
19. Osteoclast differentiation by RANKL and OPG signaling pathways. Udagawa N; Koide M; Nakamura M; Nakamichi Y; Yamashita T; Uehara S; Kobayashi Y; Furuya Y; Yasuda H; Fukuda C; Tsuda E J Bone Miner Metab; 2021 Jan; 39(1):19-26. PubMed ID: 33079279 [TBL] [Abstract][Full Text] [Related]